Cargando…
JMJD8 Is an M2 Macrophage Biomarker, and It Associates With DNA Damage Repair to Facilitate Stemness Maintenance, Chemoresistance, and Immunosuppression in Pan-Cancer
BACKGROUND: JMJD8 has recently been identified as a cancer-related gene, but current studies provide limited information. We aimed to clarify its roles and the potential mechanisms in pan-cancer. METHODS: Pan-cancer bulk sequencing data and online web tools were applied to analyze JMJD8’s correlatio...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309472/ https://www.ncbi.nlm.nih.gov/pubmed/35898493 http://dx.doi.org/10.3389/fimmu.2022.875786 |
_version_ | 1784753170743820288 |
---|---|
author | Liang, Xisong Zhang, Hao Wang, Zeyu Zhang, Xun Dai, Ziyu Zhang, Jian Luo, Peng Zhang, Longbo Hu, Jason Liu, Zaoqu Bi, Changlong Cheng, Quan |
author_facet | Liang, Xisong Zhang, Hao Wang, Zeyu Zhang, Xun Dai, Ziyu Zhang, Jian Luo, Peng Zhang, Longbo Hu, Jason Liu, Zaoqu Bi, Changlong Cheng, Quan |
author_sort | Liang, Xisong |
collection | PubMed |
description | BACKGROUND: JMJD8 has recently been identified as a cancer-related gene, but current studies provide limited information. We aimed to clarify its roles and the potential mechanisms in pan-cancer. METHODS: Pan-cancer bulk sequencing data and online web tools were applied to analyze JMJD8’s correlations with prognosis, genome instability, cancer stemness, DNA repair, and immune infiltration. Moreover, single-cell datasets, SpatialDB database, and multiple fluorescence staining were used to validate the association between JMJD8 expression and M2 macrophages. Further, we utilized ROCplotter and cMap web tool to analyze the therapeutic responses and screened JMJD8-targeted compounds, respectively, and we used AlphaFold2 and Discovery Studio to conduct JMJD8 homology modeling and molecular docking. RESULTS: We first noticed that JMJD8 was an oncogene in many cancer types. High JMJD8 was associated with lower genome stability. We then found that high JMJD8 correlated with high expression of mismatch repair genes, stemness, homologous repair gene signature in more than 9 cancers. ESTIMATE and cytokine analyses results presented JMJD8’s association with immunosuppression. Also, immune checkpoint CD276 was positively relevant to JMJD8. Subsequently, we validated JMJD8 as the M2 macrophage marker and showed its connection with other immunosuppressive cells and CD8+ T-cell depression. Finally, potential JMJD8-targeted drugs were screened out and docked to JMJD8 protein. CONCLUSION: We found that JMJD8 was a novel oncogene, and it correlated with immunosuppression and DNA repair. JMJD8 was highly associated with immune checkpoint CD276 and was an M2 macrophage biomarker in many cancers. This study will reveal JMJD8’s roles in pan-cancer and its potential as a novel therapeutic target. |
format | Online Article Text |
id | pubmed-9309472 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-93094722022-07-26 JMJD8 Is an M2 Macrophage Biomarker, and It Associates With DNA Damage Repair to Facilitate Stemness Maintenance, Chemoresistance, and Immunosuppression in Pan-Cancer Liang, Xisong Zhang, Hao Wang, Zeyu Zhang, Xun Dai, Ziyu Zhang, Jian Luo, Peng Zhang, Longbo Hu, Jason Liu, Zaoqu Bi, Changlong Cheng, Quan Front Immunol Immunology BACKGROUND: JMJD8 has recently been identified as a cancer-related gene, but current studies provide limited information. We aimed to clarify its roles and the potential mechanisms in pan-cancer. METHODS: Pan-cancer bulk sequencing data and online web tools were applied to analyze JMJD8’s correlations with prognosis, genome instability, cancer stemness, DNA repair, and immune infiltration. Moreover, single-cell datasets, SpatialDB database, and multiple fluorescence staining were used to validate the association between JMJD8 expression and M2 macrophages. Further, we utilized ROCplotter and cMap web tool to analyze the therapeutic responses and screened JMJD8-targeted compounds, respectively, and we used AlphaFold2 and Discovery Studio to conduct JMJD8 homology modeling and molecular docking. RESULTS: We first noticed that JMJD8 was an oncogene in many cancer types. High JMJD8 was associated with lower genome stability. We then found that high JMJD8 correlated with high expression of mismatch repair genes, stemness, homologous repair gene signature in more than 9 cancers. ESTIMATE and cytokine analyses results presented JMJD8’s association with immunosuppression. Also, immune checkpoint CD276 was positively relevant to JMJD8. Subsequently, we validated JMJD8 as the M2 macrophage marker and showed its connection with other immunosuppressive cells and CD8+ T-cell depression. Finally, potential JMJD8-targeted drugs were screened out and docked to JMJD8 protein. CONCLUSION: We found that JMJD8 was a novel oncogene, and it correlated with immunosuppression and DNA repair. JMJD8 was highly associated with immune checkpoint CD276 and was an M2 macrophage biomarker in many cancers. This study will reveal JMJD8’s roles in pan-cancer and its potential as a novel therapeutic target. Frontiers Media S.A. 2022-07-11 /pmc/articles/PMC9309472/ /pubmed/35898493 http://dx.doi.org/10.3389/fimmu.2022.875786 Text en Copyright © 2022 Liang, Zhang, Wang, Zhang, Dai, Zhang, Luo, Zhang, Hu, Liu, Bi and Cheng https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Liang, Xisong Zhang, Hao Wang, Zeyu Zhang, Xun Dai, Ziyu Zhang, Jian Luo, Peng Zhang, Longbo Hu, Jason Liu, Zaoqu Bi, Changlong Cheng, Quan JMJD8 Is an M2 Macrophage Biomarker, and It Associates With DNA Damage Repair to Facilitate Stemness Maintenance, Chemoresistance, and Immunosuppression in Pan-Cancer |
title | JMJD8 Is an M2 Macrophage Biomarker, and It Associates With DNA Damage Repair to Facilitate Stemness Maintenance, Chemoresistance, and Immunosuppression in Pan-Cancer |
title_full | JMJD8 Is an M2 Macrophage Biomarker, and It Associates With DNA Damage Repair to Facilitate Stemness Maintenance, Chemoresistance, and Immunosuppression in Pan-Cancer |
title_fullStr | JMJD8 Is an M2 Macrophage Biomarker, and It Associates With DNA Damage Repair to Facilitate Stemness Maintenance, Chemoresistance, and Immunosuppression in Pan-Cancer |
title_full_unstemmed | JMJD8 Is an M2 Macrophage Biomarker, and It Associates With DNA Damage Repair to Facilitate Stemness Maintenance, Chemoresistance, and Immunosuppression in Pan-Cancer |
title_short | JMJD8 Is an M2 Macrophage Biomarker, and It Associates With DNA Damage Repair to Facilitate Stemness Maintenance, Chemoresistance, and Immunosuppression in Pan-Cancer |
title_sort | jmjd8 is an m2 macrophage biomarker, and it associates with dna damage repair to facilitate stemness maintenance, chemoresistance, and immunosuppression in pan-cancer |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309472/ https://www.ncbi.nlm.nih.gov/pubmed/35898493 http://dx.doi.org/10.3389/fimmu.2022.875786 |
work_keys_str_mv | AT liangxisong jmjd8isanm2macrophagebiomarkeranditassociateswithdnadamagerepairtofacilitatestemnessmaintenancechemoresistanceandimmunosuppressioninpancancer AT zhanghao jmjd8isanm2macrophagebiomarkeranditassociateswithdnadamagerepairtofacilitatestemnessmaintenancechemoresistanceandimmunosuppressioninpancancer AT wangzeyu jmjd8isanm2macrophagebiomarkeranditassociateswithdnadamagerepairtofacilitatestemnessmaintenancechemoresistanceandimmunosuppressioninpancancer AT zhangxun jmjd8isanm2macrophagebiomarkeranditassociateswithdnadamagerepairtofacilitatestemnessmaintenancechemoresistanceandimmunosuppressioninpancancer AT daiziyu jmjd8isanm2macrophagebiomarkeranditassociateswithdnadamagerepairtofacilitatestemnessmaintenancechemoresistanceandimmunosuppressioninpancancer AT zhangjian jmjd8isanm2macrophagebiomarkeranditassociateswithdnadamagerepairtofacilitatestemnessmaintenancechemoresistanceandimmunosuppressioninpancancer AT luopeng jmjd8isanm2macrophagebiomarkeranditassociateswithdnadamagerepairtofacilitatestemnessmaintenancechemoresistanceandimmunosuppressioninpancancer AT zhanglongbo jmjd8isanm2macrophagebiomarkeranditassociateswithdnadamagerepairtofacilitatestemnessmaintenancechemoresistanceandimmunosuppressioninpancancer AT hujason jmjd8isanm2macrophagebiomarkeranditassociateswithdnadamagerepairtofacilitatestemnessmaintenancechemoresistanceandimmunosuppressioninpancancer AT liuzaoqu jmjd8isanm2macrophagebiomarkeranditassociateswithdnadamagerepairtofacilitatestemnessmaintenancechemoresistanceandimmunosuppressioninpancancer AT bichanglong jmjd8isanm2macrophagebiomarkeranditassociateswithdnadamagerepairtofacilitatestemnessmaintenancechemoresistanceandimmunosuppressioninpancancer AT chengquan jmjd8isanm2macrophagebiomarkeranditassociateswithdnadamagerepairtofacilitatestemnessmaintenancechemoresistanceandimmunosuppressioninpancancer |